To investigate the clinical application value of new pancreaticogastrostomy in laparoscopic middle segment pancreatectomy.

Clinical data of 7 patients who underwent laparoscopic middle segment pancreatectomy in the Second Hospital of Hebei Medical University from May 2022 to June 2023 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 1 patient was male and 6 female, aged from 43 to 68 years, with a median age of 52 years. 6 patients were diagnosed with serous cystadenoma of pancreas and 1 case of lobulated pancreas complicated with chronic inflammation. After laparoscopic middle segment pancreatectomy, the proximal pancreas was subject to locking suture, and the distal pancreas was anastomosed with new pancreaticogastrostomy of pancreatic duct-to-mucosa. The operation time, anastomosis time, intraoperative blood loss and postoperative complications were observed.

All 7 patients successfully completed the surgery without conversion to open surgery. The operation time was 160-260 min with a median of 200 min. The time of new pancreaticogastrostomy was 14-20 min with a median of 18 min. The intraoperative blood loss was 50-200 ml with a median of 80 ml. Postoperative abdominal infection occurred in 1 case, and no pancreatic fistula, gastric emptying disorder, postoperative bleeding or perioperative death occurred.

New pancreaticogastrostomy is simple, safe and feasible in laparoscopic middle segment pancreatectomy, which is worthy of clinical application.